We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 34 start-ups with an aggregate funding of $2.1b. The average funding per company in this subset is $61.2m.
Last update to the database: Feb 18, 2025. See changelog.
4
Funding Rounds
$49.3m
Money raised
Sphere Fluidics is a company commercializing single cell analysis systems founded in 2010 by Wilhelm Huck.
3
Funding Rounds
$183.9m
Money raised
Bit.bio is a biotechnology company that aims to operate within human cells through means of coding and biology.
3
Funding Rounds
$133.0m
Money raised
Nuclera is a provider of eProtein discovery benchtop system founded in 2013 by Jiahao Huang, Gordon McInroy and Michael Chen.
5
Funding Rounds
$30.9m
Money raised
Horizon Discovery is a company that offers gene editing, CRO, and diagnostics services
6
Funding Rounds
$2.4m
Money raised
A company that has developed software for easier access to genomic data. It is located in Cambridge, England and was founded in 2015.
8
Funding Rounds
$84.5m
Money raised
Mogrify is developing tailored cellular conversions that power future cell therapies.
13
Funding Rounds
$123.5m
Money raised
CellCentric is a clinical stage biotechnology company that focuses on developing first of its kind.
4
Funding Rounds
$420.2m
Money raised
Artios Pharma develops cancer treatments that target DNA Damage Response (DDR) Pathways to selectively kill cancer cells
1
Funding Rounds
$24.0m
Money raised
Ieso Digital Health is a Cambridge, Cambridgeshire-based digital health company offering internet enabled evidence-based psychological therapies.
4
Funding Rounds
$76.8m
Money raised
Provider of SITESEEKER platform for discovering new drugs.
5
Funding Rounds
$10.5m
Money raised
Definigen is a human Cell Models of Rare Diseases founded in 2012 by Marcus Yeo.
3
Funding Rounds
$77.0m
Money raised
PetMedix is a veterinary therapeutics biotechnology company based in Cambridge, UK. working to develop precision therapeutics to improve the health and welfare of pets.
3
Funding Rounds
$115.0m
Money raised
Platform for AI-driven drug discovery in clinical-stage development.
4
Funding Rounds
$101.6m
Money raised
Small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer
4
Funding Rounds
$166.8m
Money raised
Crescendo Biologics is an immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics.
1
Funding Rounds
$40.6m
Money raised
Therapies designed to achieve long-term disease remission with less frequent doses.
2
Funding Rounds
$20.7m
Money raised
FiveAI is an artificial Intelligence company founded in 2015 by John Redford.
10
Funding Rounds
$27.8m
Money raised
A Cambridge UK based company focused on the development of technologies for single-molecule analysis
4
Funding Rounds
$58.3m
Money raised
Epitopea is a RNA-based immunotherapies developer to treat cancer patients founded in 2021 by Jon Moore, Claude Perreault and Pierre Thibault.
2
Funding Rounds
$62.0m
Money raised
Fluidic Analytics is a tools that revolutionize how proteins are characterized founded in 2013 by Tuomas Knowles.
2
Funding Rounds
$8.2m
Money raised
CardiaTec is an AI-powered cardiovascular drug discovery platform founded in 2021 by Thelma Zablocki, Raphael Peralta and Namshik Han.
2
Funding Rounds
$19.1m
Money raised
PredictImmune is a Cambridge, Cambridgeshire-based medical diagnostics company developing diagnostic products for addressing inflammatory bowel diseases.
1
Funding Rounds
$88.0m
Money raised
Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.
4
Funding Rounds
$23.2m
Money raised
Platform for increasing protein production in the body using specialized translation enhancers.
1
Funding Rounds
$22.4m
Money raised
Cancer diagnostics.
2
Funding Rounds
$7.5m
Money raised
Contract Research Organization specializing in bioscience research services.
4
Funding Rounds
$48.0m
Money raised
Supplier of configurable process node agnostic analog IP building blocks.
1
Funding Rounds
$2.3m
Money raised
PharmEnable is an AI Drug Discovery platform founded in 2016.
1
Funding Rounds
$5.3m
Money raised
Platform that enhances images by using patented Image Fusion technology and Deep Learning to reveal more color, detail, and clarity.
2
Funding Rounds
$7.2m
Money raised
Manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications.
2
Funding Rounds
$33.5m
Money raised
Acacia Pharma is a small Molecules founded in 2006.
1
Funding Rounds
$1.3m
Money raised
Platform developing innovative drugs for cancer treatment.
1
Funding Rounds
$1.6m
Money raised
Solascure Limited is a treatment for patients with chronic wounds founded in 2017.
1
Funding Rounds
$3.0m
Money raised
Supplant is a "Biotechnology platform producing sugar substitutes.
Enter your email and get access to 71,000 + technology companies you can partner with.